PRESS RELEASE
12 June 2026

Lowenstein Represents RMG ML Sports Holdings In $200M SPAC IPO

LS
Lowenstein Sandler

Contributor

Lowenstein Sandler LLP is a national law firm with over 400 lawyers based in New York, Palo Alto, Roseland, Salt Lake City, San Francisco, and Washington, D.C. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.

Lowenstein Sandler LLP represented RMG ML Sports Holdings, a newly organized special purpose acquisition company formed as a Cayman Islands exempted company...
United States

Lowenstein Sandler LLP represented RMG ML Sports Holdings, a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, in its initial public offering of 20,000,000 units at an offering price of $10.00 per unit, The units are expected to trade on the Global Market tier of the Nasdaq stock market under the ticker symbol “SHOTU” beginning June 10, 2026. Once the securities comprising the units begin separate trading, the ordinary shares and the rights are expected to be traded on Nasdaq under the symbols “SHOT” and “SHOTR,” respectively.

RMG ML Sports Holdings intends to target opportunities in the global sports industry and adjacent sectors including, but not limited to, entertainment, eSports, gaming, music publishing and real estate development (focused on stadiums and venues).

Santander acted as sole book-running manager.

The offering is expected to close on June 11, 2026, subject to customary closing conditions.

The Lowenstein team included Daniel L. Forman, Ethan L. Silver, Victoria Jin, Keith A. Carpenter, Nathaniel A. Perle, Kristen V. Taylor, and Christopher D. Williams.

Contributor

Lowenstein Sandler LLP is a national law firm with over 400 lawyers based in New York, Palo Alto, Roseland, Salt Lake City, San Francisco, and Washington, D.C. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More